These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37899490)

  • 1. ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management.
    Rivas A; Pherwani S; Mohamed R; Smith ZL; Elmunzer BJ; Forbes N
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1101-1116. PubMed ID: 37899490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
    Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic retrograde cholangiopancreatography-related adverse events in Korea: A nationwide assessment.
    Jang DK; Kim J; Paik CN; Kim JW; Lee TH; Jang JY; Yoon SB; Lee JK
    United European Gastroenterol J; 2022 Feb; 10(1):73-79. PubMed ID: 34953054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic retrograde cholangiopancreatography-related adverse events: general overview.
    Rustagi T; Jamidar PA
    Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):97-106. PubMed ID: 25442961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Online App to Predict Post-Endoscopic Retrograde Cholangiopancreatography Adverse Events Using a Single-Center Retrospective Cohort.
    Rodrigues-Pinto E; Morais R; Sousa-Pinto B; Ferreira da Silva J; Costa-Moreira P; Santos AL; Silva M; Coelho R; Gaspar R; Peixoto A; Dias E; Baron TH; Vilas-Boas F; Moutinho-Ribeiro P; Pereira P; Macedo G
    Dig Dis; 2021; 39(3):283-293. PubMed ID: 33429393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postendoscopic retrograde cholangiopancreatography pancreatitis.
    Shih HY; Hsu WH; Kuo CH
    Kaohsiung J Med Sci; 2019 Apr; 35(4):195-201. PubMed ID: 30887733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
    Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events associated with endoscopic retrograde cholangiopancreatography: protocol for a systematic review and meta-analysis.
    Forbes N; Leontiadis GI; Vaska M; Elmunzer BJ; Yuan Y; Bishay K; Meng ZW; Iannuzzi J; O'Sullivan DE; Mah B; Partridge ACR; Henderson AM; Qureshi A; Keswani RN; Wani S; Bridges RJ; Heitman SJ; Hilsden RJ; Ruan Y; Brenner DR
    BMJ Open; 2021 Aug; 11(8):e053302. PubMed ID: 34404717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: ready for prime time?
    Parsi MA
    World J Gastroenterol; 2012 Aug; 18(30):3936-7. PubMed ID: 22912542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography.
    Inamdar S; Berzin TM; Berkowitz J; Sejpal DV; Sawhney MS; Chutanni R; Pleskow DK; Trindade AJ
    Liver Int; 2016 Oct; 36(10):1457-63. PubMed ID: 26913829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.
    Tse F; Yuan Y; Bukhari M; Leontiadis GI; Moayyedi P; Barkun A
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010571. PubMed ID: 27182692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis.
    Keswani RN; Qumseya BJ; O'Dwyer LC; Wani S
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1866-1875.e3. PubMed ID: 28606848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
    Cooper ST; Slivka A
    Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography.
    Balmadrid B; Kozarek R
    Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
    Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography.
    von Seth E; Arnelo U; Enochsson L; Bergquist A
    Liver Int; 2015 Jan; 35(1):254-62. PubMed ID: 25041074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of ERCP.
    Talukdar R
    Best Pract Res Clin Gastroenterol; 2016 Oct; 30(5):793-805. PubMed ID: 27931637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: periprocedural hydration in the prevention of post-ERCP pancreatitis.
    Smeets XJ; da Costa DW; Besselink MG; Bruno MJ; Fockens P; Mulder CJ; van der Hulst RW; Vleggaar FP; Timmer R; Drenth JP; van Geenen EJ
    Aliment Pharmacol Ther; 2016 Sep; 44(6):541-53. PubMed ID: 27444408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.